MedTrace Logo

Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis

NCT04122547 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-10-10

No results posted yet for this study

Summary

Roflumilast compare with placebo for decrease infected exacerbation in non-cystic Bronchiectasis

Conditions

Interventions

DRUG

Roflumilast

Active drug

DRUG

Placebo

Placebo one tablet oral od

Sponsors & Collaborators

  • Prince of Songkla University

    lead OTHER

Principal Investigators

  • Kanung Saejiam, MS · Prince of Songkla University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04122547 on ClinicalTrials.gov